A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia - David J. Kuter; Katsuhiro Miura; Andrea Patriarca; Dražen Pulanić; Atanas Radinoff; Katya Sapunarova; Antonia Syrigou; Renchi Yang; Van Anh Nguyen; Emily Skelton; Scarlett Wang; Donald L. Yee; et al. (New England Journal of Medicine, 2026)